There are obvious parallels between cannabis and psychedelics decriminalization. Are there are also differences?

A new psychedelics company began trading August 11th.

A measure to legalize marijuana in Arizona officially qualified for the November ballot on Monday.

Tryp Therapeutics adds a partner to advance its drug manufacturing capabilities.

Among publicly listed companies in the psychedelics space, most are psychedelics-cannabis hybrids. It actually makes a lot of sense.

Mydecine’s corporate update notes its “world’s first” clinical trials initiative for PTSD.

In the wake of Joe Biden’s selection of Kamala Harris as his running mate, Wall Street analysts are offering predictions on what the pick could mean for some key industries if the Democratic duo wins the November election.

A military vet who was sentenced to life in prison for selling $30 worth of cannabis to an undercover Louisiana police officer was recently resentenced to time served and will be released from prison.

Vermont Democratic Party insiders are including planks to decriminalize drug possession and legalize marijuana sales in a draft platform for 2020.

MindMed adds a psychedelics therapy expert to its LSD research program.